• Therapeutic Cataract & Refractive
  • Lens Technology
  • Glasses
  • Ptosis
  • AMD
  • COVID-19
  • DME
  • Ocular Surface Disease
  • Optic Relief
  • Geographic Atrophy
  • Cornea
  • Conjunctivitis
  • Myopia
  • Presbyopia
  • Allergy
  • Nutrition
  • Pediatrics
  • Retina
  • Cataract
  • Contact Lenses
  • Lid and Lash
  • Dry Eye
  • Glaucoma
  • Refractive Surgery
  • Comanagement
  • Blepharitis
  • OCT
  • Patient Care
  • Diabetic Eye Disease
  • Technology

Real-world feedback on nasal spray DED treatment


Carly Rose, OD, FAAO, shares her experience and patient feedback on implementing the first and only FDA-approved nasal spray for dry eye treatment.

Carly Rose, OD, FAAO, in practice at Eyecare on the Square in Cincinnati, Ohio, shares her experience implementing varenicline solution nasal spray (TYRVAYA, Oyster Point Pharma), the first and only FDA-approved nasal spray for dry eye treatment, in her practice, as well as the promising patient feedback she's received.

See more SECO coverage

See more dry eye content

Related Videos
R Tracy Williams, OD, FAAO, details his experience as a sports team optometrist
Bonnie An Henderson, MD, highlights key takeaways of the 2024 EnVision Summit, including diversity and family inclusion
© 2024 MJH Life Sciences

All rights reserved.